blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3735272

EP3735272 - COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  05.08.2022
Database last updated on 03.09.2024
FormerRequest for examination was made
Status updated on  09.10.2020
FormerThe international publication has been made
Status updated on  12.07.2019
Most recent event   Tooltip05.08.2022Application deemed to be withdrawnpublished on 07.09.2022  [2022/36]
Applicant(s)For all designated states
Biograph 55, Inc.
385 Oyster Point Boulevard Suite5/6
South San Francisco CA 94080 / US
[2020/46]
Inventor(s)01 / TUMEH, Paul C.
1815 Wyman Avenue, Unit B
San Francisco, California 94129 / US
 [2020/46]
Representative(s)Avidity IP
Broers Building
Hauser Forum
21 JJ Thomson Avenue
Cambridge CB3 0FA / GB
[2020/46]
Application number, filing date19736092.804.01.2019
[2020/46]
WO2019US12429
Priority number, dateUS201862614294P05.01.2018         Original published format: US 201862614294 P
[2020/46]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2019136311
Date:11.07.2019
Language:EN
[2019/28]
Type: A2 Application without search report 
No.:EP3735272
Date:11.11.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 11.07.2019 takes the place of the publication of the European patent application.
[2020/46]
Search report(s)International search report - published on:US16.04.2020
(Supplementary) European search report - dispatched on:EP25.08.2021
ClassificationIPC:A61K39/395, A61P35/00, C07K16/28
[2021/38]
CPC:
C07K16/2875 (EP,US); A61P35/00 (EP,US); A61P35/02 (US);
C07K16/2803 (US); C07K16/2818 (US); C07K16/2827 (US);
A61K2039/505 (EP); A61K2039/507 (EP,US); A61K2039/54 (US);
A61K2039/545 (US); C07K2317/24 (US); C07K2317/31 (EP,US);
C07K2317/41 (US); C07K2317/76 (EP) (-)
Former IPC [2020/46]A61K39/395
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/46]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN FÜR DIE KREBSIMMUNTHERAPIE[2020/46]
English:COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY[2020/46]
French:COMPOSITIONS ET MÉTHODES POUR L'IMMUNO-CANCÉROTHÉRAPIE[2020/46]
Entry into regional phase22.07.2020National basic fee paid 
22.07.2020Search fee paid 
22.07.2020Designation fee(s) paid 
22.07.2020Examination fee paid 
Examination procedure22.07.2020Examination requested  [2020/46]
25.03.2022Application deemed to be withdrawn, date of legal effect  [2022/36]
20.04.2022Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2022/36]
Fees paidRenewal fee
27.01.2021Renewal fee patent year 03
27.01.2022Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XY]US2017209574  (CAO ZHU ALEXANDER [US], et al) [X] 59, 61 * entire document * [Y] 60;
 [Y]US2015218267  (BRODEUR SCOTT RONALD [US], et al) [Y] 1-6 * entire document *;
 [Y]US2015125463  (COGSWELL JOHN P [US], et al) [Y] 1-6 * entire document *;
 [Y]WO2016081746  (SQUIBB BRISTOL MYERS CO [US]) [Y] 60 * entire document *;
 [PX]WO2018009904  (TUMEH PAUL C [US], et al) [PX] 1-6, 59-61 * entire document *;
 [A]US2013095097  (BLANKENSHIP JOHN W [US], et al) [A] 1-6, 59-61 * entire document *;
 [A]US9359448  (ALLAN BARRETT [US], et al) [A] 1-6, 59-61 * entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.